Noonan Syndrome and Related Disorders: A Review of Clinical Features and Mutations in Genes of the RAS/MAPK Pathway

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Hormone Research in Paediatrics

• Publication date

  2009-03-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000201106PMID 19258709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sending out an SOS

  2009cited by this paper
• Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome

  2009cited by this paper
• Abnormal Growth in Noonan Syndrome: Genetic and Endocrine Features and Optimal Treatment

  2008cited by this paper
• Analysis of the PTPN11 gene in idiopathic short stature children and Noonan syndrome patients

  2008cited by this paper
• Noonan syndrome. A review.

  2008cited by this paper
• Sending out an SOS

  2007cited by this paper
• Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype–phenotype relationships and overlap with Costello syndrome

  2007cited by this paper
• [Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation].

  2007cited by this paper
• Deregulated Ras signaling in developmental disorders: new tricks for an old dog.

  2007cited by this paper
• Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy

  2007cited by this paper
• Mild variable Noonan syndrome in a family with a novel PTPN11 mutation.

  2007cited by this paper
• Variabilidade do fenótipo de pacientes com síndrome de Noonan com e sem mutações no gene PTPN11

  2007cited by this paper
• Hyperactive Ras in developmental disorders and cancer

  2007cited by this paper
• Germline gain-of-function mutations in RAF1 cause Noonan syndrome

  2007cited by this paper
• Germline gain-of-function mutations in SOS1 cause Noonan syndrome

  2007cited by this paper
• Noonan syndrome: relationships between genotype, growth, and growth factors.

  2006cited by this paper
• The natural history of Noonan syndrome: a long-term follow-up study

  2006cited by this paper
• Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome

  2006cited by this paper
• Stops along the RAS pathway in human genetic disease

  2006cited by this paper
• Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease.

  2006cited by this paper
• Germline KRAS mutations cause Noonan syndrome

  2006cited by this paper
• Does the Rare A172G Mutation of PTPN11 Gene Convey a Mild Noonan Syndrome Phenotype?

  2006cited by this paper
• PTPN11 Gene Analysis in 74 Brazilian Patients with Noonan Syndrome or Noonan-like Phenotype

  2006cited by this paper
• Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia

  2005cited by this paper
• Diverse Biochemical Properties of Shp2 Mutants

  2005cited by this paper
• Genotypic and phenotypic characterization of Noonan syndrome: New data and review of the literature

  2005cited by this paper
• Noonan syndrome and related disorders: genetics and pathogenesis.

  2005cited by this paper
• PTPN11 mutations play a minor role in isolated congenital heart disease

  2005cited by this paper
• PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.

  2005cited by this paper
• PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.

  2005cited by this paper
• Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome.

  2004cited by this paper
• Clinical variability in a Noonan syndrome family with a new PTPN11 gene mutation

  2004cited by this paper
• Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells.

  2004cited by this paper
• Genotype-phenotype correlations in Noonan syndrome.

  2004cited by this paper
• Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia

  2004cited by this paper
• Identification of Shp-2 as a Stat5A Phosphatase*

  2003cited by this paper
• Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

  2003cited by this paper
• Regulation of IRS-1/SHP2 interaction and AKT phosphorylation in animal models of insulin resistance

  2002cited by this paper
• Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.

  2002cited by this paper
• PTPN11 mutations in LEOPARD syndrome

  2002cited by this paper
• Regulation of Insulin-like Growth Factor I Receptor Dephosphorylation by SHPS-1 and the Tyrosine Phosphatase SHP-2*

  2002cited by this paper
• Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

  2001cited by this paper
• Are Noonan syndrome and Noonan-like/multiple giant cell lesion syndrome distinct entities?

  2001cited by this paper
• Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.

  2000cited by this paper
• Involvement of the Src Homology 2-containing Tyrosine Phosphatase SHP-2 in Growth Hormone Signaling*

  1998cited by this paper
• Enhancing leptin response by preventing SH2-containing phosphatase 2 interaction with Ob receptor.

  1998cited by this paper
• Genetic analysis of protein tyrosine phosphatases.

  1998cited by this paper
• Fine mapping of Noonan/cardio-facio cutaneous syndrome in a large family

  1998cited by this paper
• Further Delineation of the Critical Region for Noonan Syndrome on the Long Arm of Chromosome 12

  1997cited by this paper
• Mapping a gene for Noonan syndrome to the long arm of chromosome 12

  1994cited by this paper
• Clinical and molecular studies in a large Dutch family with Noonan syndrome.

  1994cited by this paper
• Genetic counselling in Noonan syndrome.

  1993cited by this paper
• Noonan syndrome.

  1987cited by this paper
• Noonan syndrome: a review.

  1985cited by this paper
• A comprehensive scoring system for evaluating Noonan syndrome.

  1981cited by this paper
• The Ullrich-Noonan syndrome (Turner phenotype).

  1974cited by this paper

• A multi-dimensional approach to recognize genetic predisposition in children with acute lymphoblastic leukemia

  2025cites this paper
• A Unique Case of Aggressive Central Giant Cell Granuloma in a 10-Year-Old Boy With 16p13.11 Microdeletion Syndrome

  2022cites this paper
• Influence of Heat Stress on Intestinal Epithelial Barrier Function, Tight Junction Protein, and Immune and Reproductive Physiology

  2022cites this paper
• Delayed Puberty Phenotype Observed in Noonan Syndrome Is More Pronounced in Girls than Boys

  2022cites this paper
• The MAP3K7 gene: Further delineation of clinical characteristics and genotype/phenotype correlations

  2022cites this paper
• Involvement of MAP3K7 in FMD2 and CSCF, delineation of genotype/phenotype correlations.

  2021cites this paper
• Association between pectus excavatum and congenital genetic disorders: A systematic review and practical guide for the treating physician: pectus excavatum and congenital genetic disorders.

  2021cites this paper
• From late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns.

  2021cites this paper
• Congenital sensorineural hearing loss as the initial presentation of PTPN11-associated Noonan syndrome with multiple lentigines or Noonan syndrome: clinical features and underlying mechanisms

  2020cites this paper
• Clinical and Genetic Characteristics of Noonan Syndrome and Noonan-like Diseases

  2020influential citation
• Molecular and environmental characterization of Noonan syndrome in Morocco reveals a significant association with consanguinity and advanced parental age

  2020cites this paper
• Genetic Defects in Children with Cardiac Anomalies/Malformations: Noonan and CFC Syndromes

  2020cites this paper
• Noonan syndrome patients beyond the obvious phenotype: A potential unfavorable metabolic profile

  2020cites this paper
• Activation of the MAPK pathway (RASopathies) and partial growth hormone insensitivity.

  2020cites this paper
• Osmotic demyelination syndrome in a patient with Noonan syndrome and anterior hypopituitarism

  2020cites this paper
• Autoimmune Thyroid Disease in Specific Genetic Syndromes in Childhood and Adolescence

  2020cites this paper
• A case report of Noonan syndrome‐like disorder with loose anagen hair 2 treated with recombinant human growth hormone

  2020cites this paper
• Cardiomyopathy

  2019cites this paper
• Noonan‐Syndrom mit multiplen Lentigines und ausgeprägter Keratosis pilaris

  2019cites this paper
• Noonan syndrome with multiple lentigines and prominent keratosis pilaris

  2019cites this paper
• Pathology of Heart Disease in the Fetus, Infant and Child

  2019cites this paper
• Störungen der Geschlechtsreife

  2019cites this paper
• The diagnosis and management of congenital pulmonary valve stenosis

  2018cites this paper
• Clinical profile of comorbidity of rare diseases in a Tunisian patient: a case report associating incontinentia pigmenti and Noonan syndrome

  2018cites this paper
• First‐year growth in children with Noonan syndrome: Associated with feeding problems?

  2018cites this paper
• Comparative assessment of gene-specific variant distribution in prenatal and postnatal cohorts tested for Noonan syndrome and related conditions

  2018cites this paper
• Growth Hormone's Links to Cancer.

  2018cites this paper
• Contribution of Chromosomal Microarray Analysis in fetuses with Increased Nuchal Translucency: A Prospective Observational Study

  2018cites this paper
• Growth hormone therapy in patients with Noonan syndrome

  2018cites this paper
• Study of Ras/MAPK pathway gene variants in Chilean patients with Cryptorchidism

  2018cites this paper
• Involvement of P38 and ERK1/2 in mitochondrial pathways independent cell apoptosis in oviduct magnum epithelial cells of layers challenged with vanadium

  2018cites this paper
• Vanadate oxidative and apoptotic effects are mediated by the MAPK-Nrf2 pathway in layer oviduct magnum epithelial cells.

  2017cites this paper
• Further Evidence for the Implication of LZTR1, a Gene not Associated with the Ras-Mapk Pathway, in the Pathogenesis of Noonan Syndrome

  2017cites this paper
• Noonan Syndrome Eye Signs: A Case Report

  2017cites this paper
• Neurofibromatosis-Noonan Syndrome: A Possible Paradigm of the Combination of Genetic and Epigenetic Factors.

  2017cites this paper
• Copy number variants of Ras/MAPK pathway genes in patients with isolated cryptorchidism

  2017cites this paper
• Motor performance in children with Noonan syndrome

  2017cites this paper
• Rare copy number variants in patients with congenital conotruncal heart defects.

  2017cites this paper
• Challenges in prenatal screening and diagnosis in the Netherlands

  2017cites this paper
• Genetic short stature.

  2017cites this paper
• Chondrosarcoma in Metachondromatosis: A Rare Case Report.

  2017influential citation
• Perceived motor problems in daily life: Focus group interviews with people with Noonan syndrome and their relatives

  2016cites this paper
• The regulation of male fertility by the PTPN11 tyrosine phosphatase.

  2016cites this paper
• Prenatal DNA diagnosis of Noonan syndrome in a fetus with increased nuchal translucency using next-generation sequencing.

  2016cites this paper
• Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors?

  2016cites this paper
• A Unique Case of a 12-Year-Old Boy With Noonan Syndrome Combined With Noncompaction of the Ventricular Myocardium.

  2016cites this paper
• Mutation Spectrum and Phenotypic Features in Noonan Syndrome with PTPN11 Mutations: Definition of Two Novel Mutations

  2016cites this paper
• Noonan syndrome – a new survey

  2016cites this paper
• Insights into K-Ras 4B regulation by post-translational lysine acetylation

  2016cites this paper
• Motor Delays: Early Identification and Evaluation abstractenencounterchildrenwithdelaysofmotordevelopment

  2016cites this paper
• Functional Toxicogenomic Assessment of Triclosan in Human HepG2 Cells Using Genome-Wide CRISPR-Cas9 Screening.

  2016cites this paper
• Autoimmune liver disease in Noonan Syndrome.

  2015cites this paper
• Skeletal muscle and motor deficits in Neurofibromatosis Type 1

  2015cites this paper
• Deformidad vertebral en el Síndrome de Noonan: revisión de la literatura. A propósito de dos casos

  2015cites this paper
• Nonspecific phenotype of Noonan syndrome diagnosed by whole exome sequencing

  2015cites this paper
• Malformación de Arnold-Chiari en el síndrome de Noonan y otros síndromes de la vía RAS/MAPK

  2015cites this paper
• [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].

  2015cites this paper
• Pulmonary Stenosis and Insufficiency

  2014cites this paper
• Case-only exome sequencing and complex disease susceptibility gene discovery: study design considerations

  2014cites this paper
• Increased nuchal translucency with normal karyotype and anomaly scan: what next?

  2014cites this paper
• Syndromic Disorders with Short Stature

  2014influential citation
• Noonan syndrome

  2014cites this paper
• Silica nanoparticles induce endoplasmic reticulum stress response, oxidative stress and activate the mitogen-activated protein kinase (MAPK) signaling pathway

  2014cites this paper
• Applying next generation sequencing to skeletal development and disease

  2014cites this paper
• Noonan Syndrome: Comparing Mutation-Positive with Mutation-Negative Dutch Patients

  2013cites this paper
• The Tyrosine Phosphatase SHP 2 Regulates Sertoli Cell Junction Complexes 1

  2013cites this paper
• Cardiac manifestations of cutaneous disorders.

  2013cites this paper
• Metachondromatosis: more than just multiple osteochondromas

  2013influential citation
• The Tyrosine Phosphatase SHP2 Regulates Sertoli Cell Junction Complexes1

  2013cites this paper
• Motor Delays: Early Identification and Evaluation

  2013cites this paper
• Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery–Dreifuss muscular dystrophy plus phenotype

  2013cites this paper
• Involvement of oxidative stress and mitogen-activated protein kinase signaling pathways in heat stress-induced injury in the rat small intestine

  2013cites this paper
• Cognition and emotion in adults with Noonan syndrome. A neuropsychological perspective

  2013cites this paper
• Cerium oxide nanoparticles induce cytotoxicity in human hepatoma SMMC-7721 cells via oxidative stress and the activation of MAPK signaling pathways.

  2013cites this paper
• MAPK activation in mature cataract associated with Noonan syndrome

  2013cites this paper
• Noonan syndrome and RASopathies: Clinical features, diagnosis and management

  2012influential citation
• A new nonsense mutation in the NF1 gene with neurofibromatosis–Noonan syndrome phenotype

  2012cites this paper
• Gianotti–Crosti Syndrome After Childhood Vaccination

  2012cites this paper
• Segmental Becker’s Nevi with Mucosal Involvement

  2012cites this paper
• Growth standards of patients with Noonan and Noonan‐like syndromes with mutations in the RAS/MAPK pathway

  2012cites this paper
• Atypical Granular Cell Tumor Occurring in an Individual with Noonan Syndrome Treated with Growth Hormone

  2012cites this paper
• C4ST-1/CHST11-controlled chondroitin sulfation interferes with oncogenic HRAS signaling in Costello syndrome

  2012cites this paper
• Targeted ultrasound examination and DNA testing for Noonan syndrome, in fetuses with increased nuchal translucency and normal karyotype

  2011cites this paper
• Funktionelle Charakterisierung von Neurofibromin in der Entwicklung des muskuloskelettalen Systems

  2011cites this paper
• Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment

  2011cites this paper
• Loss-of-Function Mutations in PTPN11 Cause Metachondromatosis, but Not Ollier Disease or Maffucci Syndrome

  2011cites this paper
• Genetic, epigenetic and functional analysis of tumorigenesis in neurofibromatosis type 1 (NF1)

  2011cites this paper
• Ras in cancer and developmental diseases.

  2011cites this paper
• Orthopaedic Conditions in Ras/MAPK Related Disorders

  2011cites this paper
• Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis.

  2011cites this paper
• Growth hormone, the insulin-like growth factor axis, insulin and cancer risk

  2011cites this paper
• Testicular size development and reproductive hormones in boys and adult males with Noonan syndrome: a longitudinal study.

  2011cites this paper
• King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene.

  2011cites this paper
• Das Noonan-Syndrom

  2011cites this paper
• Hypofunction of the Testes

  2011cites this paper
• Heritability of hematologic malignancies: from pedigrees to genomics.

  2010cites this paper
• Pulmonary stenosis as a predisposing factor for infective endocarditis in a patient with Noonan syndrome.

  2010cites this paper
• Prenatal detection of Noonan syndrome by mutation analysis of the PTPN11 and the KRAS genes

  2010influential citation
• Giant Cell Lesions in Noonan Syndrome: Case Report and Review of The Literature

  2010cites this paper
• Whole-Genome Sequencing of a Single Proband Together with Linkage Analysis Identifies a Mendelian Disease Gene

  2010cites this paper